Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Aclaris Therapeutics, Inc.
What AI says about Aclaris Therapeutics, Inc.
Aclaris Therapeutics is dedicated to translating scientific discoveries into effective therapies for underserved immuno-inflammatory conditions. Utilizing their proprietary KINect technology platform, they develop novel small and large molecule drugs as well as biologic therapies.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Not in this profile yet:
Products & Services
Drug Discovery and Development
Aclaris focuses on developing novel small and large molecule drugs targeting immuno-inflammatory conditions through kinase inhibition.
Biologic Product Candidates
Development of monoclonal and bispecific antibodies aimed at addressing unmet needs in immune-inflammatory diseases.
Confluence Discovery Technologies
A full-service drug discovery and early development contract research organization that partners with pharma and biotech companies.
Common Questions
What conditions does Aclaris Therapeutics focus on?
Aclaris Therapeutics focuses on immuno-inflammatory conditions and aims to develop therapies for underserved areas.
What technology does Aclaris use for drug development?
Aclaris utilizes the proprietary KINect technology platform to innovate and develop new small molecule medicines.
What types of therapies does Aclaris develop?
Aclaris develops both small and large molecule drugs, as well as biologic therapies like monoclonal and bispecific antibodies.
What is Confluence Discovery Technologies?
Confluence Discovery Technologies is a contract research organization operated by Aclaris that provides drug discovery and early development services.
Who are Aclaris's partners?
Aclaris partners with pharmaceutical and biotech companies across various therapeutic areas for drug discovery.